Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

Giugliani Roberto; Scarpa Maurizio; Tylki-Szymanska Anna; Beck Michael; Jego Virginie; Muenzer Joseph

首页> 外文期刊>Molecular genetics and metabolism >Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

【24h】

Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

机译：MPS II患者患者II患者治疗后3年后的临床结果：来自猎人结果调查（HOS）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Molecular genetics and metabolism》 |2017年第2期|共1页
作者
Giugliani Roberto; Scarpa Maurizio; Tylki-Szymanska Anna; Beck Michael; Jego Virginie; Muenzer Joseph;
展开▼
作者单位

Hosp Clin Porto Alegre Porto Alegre RS Brazil;

Helios Dr Horst Schmidt Clin Wiesbaden Germany;

Childrens Mem Hlth Inst Warsaw Poland;

Johannes Gutenberg Univ Mainz Mainz Germany;

Cytel Inc Geneva Switzerland;

Univ North Carolina Chapel Hill Chapel Hill NC USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS) [J] . Giugliani Roberto, Scarpa Maurizio, Tylki-Szymanska Anna, Molecular genetics and metabolism . 2017,第1a2期

机译：MPS II患者患者II患者治疗后3年后的临床结果：来自猎人结果调查（HOS）
2. Profile of patients with mucopolysaccharidosis type II without cognitive impairment who started idursulfase treatment aged > 20 years: data on late treatment initiation from the Hunter Outcome Survey (HOS) [J] . Lau Heather A., Hennermann Julia, Guffon Nathalie, Molecular genetics and metabolism . 2017,第1a2期

机译：含有粘性蛋白病患者II患者的概况，没有认知障碍，他们开始IDUSULFASE治疗> 20年的治疗：关于猎人结果调查（HOS）的晚期治疗启动数据
3. Profile of patients with mucopolysaccharidosis type II without cognitive impairment who started idursulfase treatment aged > 20 years: data on late treatment initiation from the Hunter Outcome Survey (HOS) [J] . Lau Heather A., Hennermann Julia, Guffon Nathalie, Molecular genetics and metabolism . 2017,第1a2期

机译：含有粘性蛋白病患者II患者的概况，没有认知障碍，他们开始IDUSULFASE治疗> 20年的治疗：关于猎人结果调查（HOS）的晚期治疗启动数据
4. Data Mining Session-Based Patient Reported Outcomes (PROs) in a Mental Health Setting: Toward Data-Driven Clinical Decision Support and Personalized Treatment [C] . Bennett Casey, Doub Thomas, Bragg April, 2011 First IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology . 2011

机译：在精神健康环境中基于数据挖掘会话的患者报告结果（PRO）：寻求数据驱动的临床决策支持和个性化治疗
5. A comparison of treatment outcomes across OCD symptom dimensions in a clinical sample of OCD patients [D] . Little, Tannah E. 2012

机译：在强迫症患者的临床样本中，跨强迫症症状范围的治疗结果比较
6. Clinical outcomes in idursulfase-treatedpatients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey(HOS) [O] . Joseph Muenzer, Roberto Giugliani, Maurizio Scarpa, 2017

机译：异硫磺酶治疗的临床结果II型粘多糖贮积症患者：猎人结果调查的3年数据（HOS）
7. Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II:data from the Hunter Outcome Survey (HOS) [O] . Burton, Barbara K., Jego, Virginie, Mikl, Jaromir, 2017

机译：患有idurulfase治疗和未治疗的II型粘多糖贮积症患者的生存率：来自Hunter Outcome survey（HOs）的数据

Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

著录项

引文网络

相似文献

相关主题

期刊订阅